Check out your Company Bowl for anonymous work chats.
The industry is witnessing a pivotal moment with the loss of exclusivity for adalimumab, marking the largest event of its kind. Several adalimumab biosimilars have entered the market, and more are expected to follow. As competition intensifies, PBMs and manufacturers must strategically position themselves in the market. Amplity's Nikolina Janakievski, Associate Director and Lead Strategist, Market Access, co-published this article for Life Science Leader to delve into the strategies necessary to navigate this evolving landscape, demonstrating how Amplity's market access team is equipped to provide the creative strategy and predictive analytics necessary to execute a successful biosimilar launch. Visit https://lnkd.in/ebq6PcnS to read a copy of the Life Science Leader article.
The industry is witnessing a pivotal moment with the loss of exclusivity for adalimumab, marking the largest event of its kind. Several adalimumab biosimilars have entered the market, and more are expected to follow. As competition intensifies, PBMs and manufacturers must strategically position themselves in the market. Amplity's Nikolina Janakievski, Associate Director and Lead Strategist, Market Access, co-published this article for Life Science Leader to delve into the strategies necessary to navigate this evolving landscape, demonstrating how Amplity's market access team is equipped to provide the creative strategy and predictive analytics necessary to execute a successful biosimilar launch. Visit https://lnkd.in/ebq6PcnS to read a copy of the Life Science Leader article.
Amplity Health is proud to announce our participation in the upcoming HBA's 2023 Annual Conference. The event promises to be a dynamic gathering of healthcare leaders, and we've got an exceptional team representing us, including Cecily Tibbs Peters. Cecily summed up her anticipation beautifully: "I am excited to learn from and share with so many dynamic women in healthcare as we all strive toward gender parity. I am honored to be able to share some of this HBA experience with Team Amplity, the customers with whom we engage, and the patients that we all serve." Joining Cecily are Christina, Erica, and Samantha. Stay tuned for insights and inspiration from this incredible event. #powerthepossibilities #HBA23 #HBA
Amplity Commercial Solutions has supported oncology launches with companies from the top 5 global pharma companies to the innovative small to mid-sized biotechs over the past several years. More than 85% of our work is in oncology and specialty therapies, and we have successfully supported launches across 20+ tumor types. Visit https://lnkd.in/eGGkeapF to learn why you should talk to Amplity Commercial Solutions as you’re planning your product launch.
Today is the first day of National Health Education Week. We take our role of educating treatment teams - physicians, payers, and patients - on behalf of our pharmaceutical clients very seriously. Through rigorous education and awareness, we hope to help our clients' patients gain access to the right medicine.
Manufacturers need every advantage to make informed decisions and effectively bring their products to market. Read the newest article from the Amplity Insights team to learn how the innovative use of NLP algorithms to extract insights from physician-patient interactions is proving to be a game-changer: https://lnkd.in/eujzmPE6
Amplity's Anna and Nicoletta are traveling to Madrid for #ESMO23! 85% of our work is in oncology, so we're devoted to attending events like ESMO to meet with pharma and biotech companies looking for a #MedicalScienceLiaison #ClinicalTrialLiaison #PrecisionMedicineLiaison #LaboratoryScienceLiaison outsourcing partner. Message them directly here on LinkedIn to arrange a time to learn how we're delivering tailored medical and clinical solutions that scale throughout the lifecycle of oncology drugs.
Amplity is a proud corporate partner of the Healthcare Businesswomen's Association - Entrepreneurship (HBA), an organization dedicated to furthering the advancement and impact of women in the business of healthcare. Amplity’s Cecily Tibbs Peters, Christina DiBiase, Erica Smith, and Samantha DiClementi are active members of the HBA, and are attending their 2023 Annual Conference next month. Christina explained, “The HBA annual conference brings together healthcare experts who embody the spirit that anything is possible. The conference is a place where industry visionaries continue to challenge you out of your comfort zone and cheer you on as you reach new heights. I’m grateful that Amplity continues to invest in leadership growth and development through the HBA.” #powerthepossibilities #HBA #HBA23
Amplity’s Commercial Solutions professionals drive uptake of pharmaceutical products through personal and nonpersonal channels. We deliver peak brand performance by first developing scientific understanding and relative value to influence today’s interwoven web of decision makers. Contact Christina DiBiase, Head of Commercial Solutions, to discuss how to customize your outsourced commercial program.
Amplity Health and Viver Health LLC have partnered to provide support for key stakeholders in the rare disease space by better understanding the patient care dynamic, now and in the future; identifying clinical and nonclinical experts and patients; and creating integrated solutions that improve access to clinical trials and available care, and enhance clinical outcomes. Contact Stephen Solano or Victoria Barghout for more information.
